Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

Sanofi reception

Sanofi and Translate Bio eye launch of phase 1/2 COVID-19 vaccine study

Preclinical data for mRNA-based vaccine supports clinical development

- PMLiVE

Best practice in UK diabetes celebrated at virtual QiC Diabetes Awards 2020

Award ceremony was held virtually this year due to COVID-19 pandemic

‘It’s not about you, it’s about them’ – putting customer needs first in our communications

By Chris Finch

- PMLiVE

Novartis’ MS therapy Mayzent approved by NICE

Agency approves drug after new cost-effectiveness proposal

Harnessing Technology to Improve Health and Healthcare

Steven Collens, Chief Executive Officer at MATTER, discusses his professional journey, his work to empower digital health technology startups, and how MATTER is helping businesses define their challenges, identify solutions, and innovate...

Impetus Digital

Telemedicine and the Digitization of Medicine post COVID-19

Samantha Lippolis, Telehealth Advisor at Sam I am Innovates; Dr. Daniel Fagbuyi, CEO of Erudition; Dr. Brian Block, Health Care Consultant at Brian Block Consulting; Mindy Klowden, Director of Strategic Initiatives at the Colorado Behavioral Healthcare...

Impetus Digital

Innovative Medical Solutions for Postponing and Undoing Age-related Disease

Aubrey de Grey, Chief Science Officer at SENS Research Foundation, explores the concept of using biomedical technology and regenerative medicine to postpone aging-derived debilitation and death. We dive into many questions surrounding...

Impetus Digital

- PMLiVE

BiTE* platform and the evolution toward off-the-shelf immuno-oncology approaches

By Peter Kufer

- PMLiVE

Regeneron scores first FDA approval for Ebola antibody treatment

Treatment cut mortality rate in study based in the Democratic Republic of Congo

- PMLiVE

Biopharma industry encouraged by EMA’s COVID-19 transparency measures

IFPMA and EFPIA welcome new transparency measures for potential treatments and vaccines

- PMLiVE

Roche to collaborate with Dyno on gene therapies for CNS/liver diseases

Dyno will use its CapsidMap platform to develop novel AAV vectors for improved gene therapies

- PMLiVE

Looking after the mental wellbeing of the Porterhouse family

At Porterhouse Medical Group, as a busy insight-led healthcare communications agency group, we recognise the importance of mental health and that mental health issues are a normal part of life...

Porterhouse Medical Group

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links